151 related articles for article (PubMed ID: 21562974)
1. Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion.
Huang MH; Wu Y; Nguyen V; Rastogi S; McConnell BK; Wijaya C; Uretsky BF; Poh KK; Tan HC; Fujise K
Cardiovasc Drugs Ther; 2011 Jun; 25(3):223-32. PubMed ID: 21562974
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic synergy and complementarity for ischemia/reperfusion injury: β1-adrenergic blockade and phosphodiesterase-3 inhibition.
Huang MH; Poh KK; Tan HC; Welt FG; Lui CY
Int J Cardiol; 2016 Jul; 214():374-80. PubMed ID: 27085132
[TBL] [Abstract][Full Text] [Related]
3. Cyclic nucleotide phosphodiesterase 3A1 protects the heart against ischemia-reperfusion injury.
Oikawa M; Wu M; Lim S; Knight WE; Miller CL; Cai Y; Lu Y; Blaxall BC; Takeishi Y; Abe J; Yan C
J Mol Cell Cardiol; 2013 Nov; 64():11-9. PubMed ID: 23988739
[TBL] [Abstract][Full Text] [Related]
4. Administration of milrinone before ischemia, in the presence of beta-blockade, to treat metabolic impairment and myocardial stunning in pigs.
Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
Acta Anaesthesiol Scand; 2008 Mar; 52(3):397-405. PubMed ID: 18269389
[TBL] [Abstract][Full Text] [Related]
5. Infusion of esmolol attenuates lipopolysaccharide-induced myocardial dysfunction.
Wang Z; Wu Q; Nie X; Guo J; Yang C
J Surg Res; 2016 Jan; 200(1):283-9. PubMed ID: 26316443
[TBL] [Abstract][Full Text] [Related]
6. Reducing ischaemia/reperfusion injury through delta-opioid-regulated intrinsic cardiac adrenergic cells: adrenopeptidergic co-signalling.
Huang MH; Nguyen V; Wu Y; Rastogi S; Lui CY; Birnbaum Y; Wang HQ; Ware DL; Chauhan M; Garg N; Poh KK; Ye L; Omar AR; Tan HC; Uretsky BF; Fujise K
Cardiovasc Res; 2009 Dec; 84(3):452-60. PubMed ID: 19581316
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.
Wang Z; Wu Q; Nie X; Guo J; Yang C
Clin Drug Investig; 2015 Nov; 35(11):707-16. PubMed ID: 26387030
[TBL] [Abstract][Full Text] [Related]
8. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection.
Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F
Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901
[TBL] [Abstract][Full Text] [Related]
9. Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs.
Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
Br J Anaesth; 2006 Dec; 97(6):799-807. PubMed ID: 17035336
[TBL] [Abstract][Full Text] [Related]
10. Safety of combination therapy with milrinone and esmolol for heart protection during percutaneous coronary intervention in acute myocardial infarction.
Poh KK; Xu X; Chan MY; Lee CH; Tay EL; Low AF; Chan KH; Sia W; Tang LQ; Tan HC; Lui CY; Nguyen V; Fujise K; Huang MH
Eur J Clin Pharmacol; 2014 May; 70(5):527-30. PubMed ID: 24463539
[TBL] [Abstract][Full Text] [Related]
11. Combination of the Phosphodiesterase Inhibitors Sildenafil and Milrinone Induces Cardioprotection With Various Conditioning Strategies.
Torregroza C; Maas K; Feige K; Raupach A; Stroethoff M; Heinen A; Hollmann MW; Huhn R
J Cardiovasc Pharmacol; 2020 Dec; 76(6):684-691. PubMed ID: 33002964
[TBL] [Abstract][Full Text] [Related]
12. Effects of milrinone on left ventricular cardiac function during cooling in an intact animal model.
Tveita T; Sieck GC
Cryobiology; 2012 Aug; 65(1):27-32. PubMed ID: 22465655
[TBL] [Abstract][Full Text] [Related]
13. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
[TBL] [Abstract][Full Text] [Related]
14. Activation of Akt/GSK-3beta signaling pathway is involved in intermedin(1-53) protection against myocardial apoptosis induced by ischemia/reperfusion.
Song JQ; Teng X; Cai Y; Tang CS; Qi YF
Apoptosis; 2009 Sep; 14(9):1061-9. PubMed ID: 19634012
[TBL] [Abstract][Full Text] [Related]
15. Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2002 Aug; 124(2):340-51. PubMed ID: 12167795
[TBL] [Abstract][Full Text] [Related]
16. Milrinone-induced postconditioning reduces hepatic ischemia-reperfusion injury in rats: the roles of phosphatidylinositol 3-kinase and nitric oxide.
Toyoda T; Tosaka S; Tosaka R; Maekawa T; Cho S; Eguchi S; Nakashima M; Sumikawa K
J Surg Res; 2014 Jan; 186(1):446-51. PubMed ID: 24120242
[TBL] [Abstract][Full Text] [Related]
17. Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats.
Suzuki T; Morisaki H; Serita R; Yamamoto M; Kotake Y; Ishizaka A; Takeda J
Crit Care Med; 2005 Oct; 33(10):2294-301. PubMed ID: 16215384
[TBL] [Abstract][Full Text] [Related]
18. Effects of Combined Milrinone and Levosimendan Treatment on Systolic and Diastolic Function During Postischemic Myocardial Dysfunction in a Porcine Model.
Axelsson B; Häggmark S; Svenmarker S; Johansson G; Gupta A; Tydén H; Wouters P; Haney M
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):495-503. PubMed ID: 26837238
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent Effects of Esmolol-epinephrine Combination Therapy in Myocardial Ischemia and Reperfusion Injury.
Oyama Y; Blaskowsky J; Eckle T
Curr Pharm Des; 2019; 25(19):2199-2206. PubMed ID: 31258066
[TBL] [Abstract][Full Text] [Related]
20. Milrinone and esmolol decrease cardiac damage after resuscitation from prolonged cardiac arrest.
Zoerner F; Lennmyr F; Wiklund L; Martijn C; Semenas E
Acta Anaesthesiol Scand; 2015 Apr; 59(4):465-74. PubMed ID: 25790148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
